维生素C预防冠状病毒

使用者Orthomolecular Medicine News Service细胞分子矫正医学新闻着作:Dr Andrew WSaul (Editor in Chief for Orthomolecular Medicine News Service)

随着“高浓度(大剂量)维生素C”立即的广泛使用,冠状病毒大流行可以显著减缓或停止。数十年来,各国的医生们已证明维生素C具有强大的抗病毒作用。媒体⻓期以来普遍缺乏报导这种有效而成功的方法来对抗病毒,尤其是当今我们所面对的冠状病毒。在平日的预防保健最重要的是“最大化人体的抗氧化能力和其自身的免疫能力,以预防和最小化病毒攻击人体时的症状。”人体自身的宿主环境至关重要。预防显然比治疗严重疾病容易许多。但是要严肃来治疗严重疾病,不要犹豫去寻求医疗救助。这不是一个非此即彼的选择。维生素C是可以与药物一起合并使用来治疗严重疾病。

“我还未⻅过有任何感冒不能被“高浓度(大剂量)维生素C治愈或得到明显缓解。”(Robert F. Cathcart, MD)

“细胞分子矫正医学新闻服务社”(Orthomolecular Medicine News Service)和“国际细胞分子矫正医学会”(ISOM, International Society for Orthomolecular Medicine)的专家医生们呼吁以营养素为基础的方法来预防或最大程度地减少未来病毒感染的症状。服用以下便宜补充品是成人推荐量。而有关孩童请根据其体重改变剂量。(注:若需要进一步免费中文谘询,欢迎联系TSOM )

  • 维生素C:3,000mg/日(或更多。分次服用)
  • 维生素D3: 2,000IU/日(从5,000IU/日开始,持续两周,然后减少到2,000IU)
  • 镁: 400 mg /日(柠檬酸镁,苹果酸镁,作为镁合物或氯化镁)
  • 锌:20 mg/日
  • 硒:100 μg/日

维生素C[1],维生素D[2],镁[3],锌[4]和硒[5]已经被证实增强对抗病毒的免疫功能“使用高浓度(大剂量)维生素C ”来预防和治疗病毒性疾病的临床基础实证可以被追溯至维生素C 成功治疗小儿麻痺症(脊髓灰质炎病毒)在1940年代末被首次报导[6]。关于这个事实,有很多人根本没有注意过,甚至很多人是非常惊讶地。然后,临床证据已经建立了超过几十年,而在1980 年出版了《病毒性疾病的治疗方案》。[7]

高浓度维生素C 在预防和治疗呼吸道感染方面的有效性已经得到证实。那些认为维生素C 本身有优点,但认为在高浓度下使用效果不佳或对身体有不良影响的团体,我建议请他们自己好好阅读原始论文。这些医生的研究被忽视是很久以前的事了,忽视造成更重要的问题就是:在这种病毒性疾病爆发的情况下,为什么这些重要和有用的医疗资讯不能从政府组织向公众传播?紧急公告“我还未⻅过有任何感冒不能被“高浓度(大剂量)维生素C治愈或得到明显缓解。”(Robert F. Cathcart, MD)Vitamin C Protects Against Coronavirus维生素C预防冠状病毒TSOM Taiwanese Society for Orthomolecular Medicine 授权翻译此文中文版

参考文献:1.Vitamin C:Case HS (2018) Vitamin C questions answered. Orthomolecular Medicine News Service, http://orthomolecular.org/resources/omns/v14n12.shtml. Gonzalez MJ, Berdiel MJ, Duconge J (2018) High dose vitamin C and influenza: A case report. J Orthomol Med. June, 2018, 33(3). https://isom.ca/article/high-dose-vitamin-c-influenza-case-report. Gorton HC, Jarvis K (1999) The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manip Physiol Ther, 22:8, 530-533. https://www.ncbi.nlm.nih.gov/pubmed/10543583Hemilä H (2017) Vitamin C and infections. Nutrients. 9(4). pii:E339. https://www.ncbi.nlm.nih.gov/pubmed/28353648. Hickey S, Saul AW (2015) Vitamin C: The real story. Basic Health Pub. ISBN-13: 978-1591202233.Levy TE (2014) The clinical impact of vitamin C. Orthomolecular Medicine News Service, http://orthomolecular.org/resources/omns/v10n14.shtmlOMNS (2007) Vitamin C: a highly effective treatment for colds. http://orthomolecular.org/resources/omns/v03n05.shtml. OMNS (2009) Vitamin C as an antiviral http://orthomolecular.org/resources/omns/v05n09.shtml. Taylor T (2017) Vitamin C material: where to start, what to watch. OMNS, http://www.orthomolecular.org/resources/omns/v13n20.shtml. Yejin Kim, Hyemin Kim, SeyeonBae et al. (2013) Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-α/β at the initial stage of influenza A virus (H3N2) infection. Immune Netw. 13:70-74. https://www.ncbi.nlm.nih.gov/pubmed/23700397.

2.Vitamin D:Cannell JJ, Vieth R, Umhau JC et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect. 134:1129-1140. https://www.ncbi.nlm.nih.gov/pubmed/16959053. Cannell JJ, Zasloff M, Garland CF et al. (2008) On the epidemiology of influenza. Virol J. 5:29. https://www.ncbi.nlm.nih.gov/pubmed/16959053. Ginde AA, Mansbach JM, Camargo CA Jr. (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 169:384-390. https://www.ncbi.nlm.nih.gov/pubmed/19237723. Martineau AR, Jolliffe DA, Hooper RL et al. (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 356:i6583. https://www.ncbi.nlm.nih.gov/pubmed/28202713. Urashima M, Segawa T, Okazaki M et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 91:1255-60. https://www.ncbi.nlm.nih.gov/pubmed/20219962.von Essen MR, Kongsbak M, Schjerling P et al. (2010) Vitamin D controls T cell antigen receptorsignaling and activation of human T cells. Nat Immunol. 11:344-349. https://www.ncbi.nlm.nih.gov/pubmed/20208539.

3.Magnesium: Dean C (2017) Magnesium. OMNS, http://www.orthomolecular.org/resources/omns/v13n22.shtmlDean C. (2017) The Magnesium Miracle. 2nd Ed., Ballantine Books. ISBN-13: 978-0399594441. Levy TE (2019) Magnesium: Reversing Disease. Medfox Pub. ISBN-13: 978-0998312408

4.Zinc: Fraker PJ, King LE, Laakko T, Vollmer TL. (2000) The dynamic link between the integrity of the immune system and zinc status. J Nutr. 130:1399S-406S. https://www.ncbi.nlm.nih.gov/pubmed/10801951. Liu MJ, Bao S, Gálvez-Peralta M, et al. (2013) ZIP8 regulates host defense through zinc-mediated inhibition of NF-кB. Cell Rep. 3:386-400. https://www.ncbi.nlm.nih.gov/pubmed/23403290. Mocchegiani E, Muzzioli M. (2000) Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr. 130:1424S-1431S. https://www.ncbi.nlm.nih.gov/pubmed/10801955.Shankar AH, Prasad AS. (1998) Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 68:447S-463S. https://www.ncbi.nlm.nih.gov/pubmed/9701160.

5.Selenium: Beck MA, Levander OA, Handy J. (2003) Selenium deficiency and viral infection. J Nutr. 133:1463S1467S. https://www.ncbi.nlm.nih.gov/pubmed/12730444. Hoffmann PR, Berry MJ. (2008) The influence of selenium on immune responses. Mol Nutr Food Res. 52:1273-1280. https://www.ncbi.nlm.nih.gov/pubmed/18384097. Steinbrenner H, Al-Quraishy S, Dkhil MA et al. (2015) Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr. 6:73-82. https://www.ncbi.nlm.nih.gov/pubmed/25593145. 6. Klenner FR. The treatment of poliomyelitis and other virus diseases with vitamin C. J South Med Surg 1949, 111:210-214. http://www.doctoryourself.com/klennerpaper.html. 7. Cathcart RF. The method of determining proper doses of vitamin C for treatment of diseases by titrating to bowel tolerance. Australian Nurses J 1980, 9(4):9-13. http://www.doctoryourself.com/titration.html

编辑委员:Ilyès Baghli, M.D. (Algeria) Ian Brighthope, M.D. (Australia) Prof. Gilbert Henri Crussol (Spain) Carolyn Dean, M.D., N.D. (USA) Damien Downing, M.D. (United Kingdom) Michael Ellis, M.D. (Australia) Martin P. Gallagher, M.D., D.C. (USA) Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico) William B. Grant, Ph.D. (USA) Tonya S. Heyman, M.D. (USA) Suzanne Humphries, M.D. (USA) Ron Hunninghake, M.D. (USA) Michael Janson, M.D. (USA) Robert E. Jenkins, D.C. (USA) Bo H. Jonsson, M.D., Ph.D. (Sweden) Jeffrey J. Kotulski, D.O. (USA)Peter H. Lauda, M.D. (Austria) Thomas Levy, M.D., J.D. (USA) Homer Lim, M.D. (Philippines) Stuart Lindsey, Pharm.D. (USA) Victor A. Marcial -Vega, M.D. (Puerto Rico) Charles C. Mary, Jr., M.D. (USA) Mignonne Mary, M.D. (USA)Jun Matsuyama, M.D., Ph.D. (Japan) Dave McCarthy, M.D. (USA) Joseph Mercola, D.O. (USA) Jorge R. Miranda -Massari, Pharm.D. (Puerto Rico) Karin Munsterhjelm -Ahumada, M.D. (Finland) Tahar Naili, M.D. (Algeria) W. Todd Penberthy, Ph.D. (USA) Dag Viljen Poleszynski, Ph.D. (Norway) Jeffrey A. Ruterbusch, D.O. (USA)Gert E. Schuitemaker, Ph.D. (Netherlands) Thomas L. Taxman, M.D. (USA) Jagan Nathan Vamanan, M.D. (India) Garry Vickar, MD (USA) Ken Walker, M.D. (Canada) Anne Zauderer, D.C. (USA) Andrew W. Saul, Ph.D. (USA), Editor -In -Chief Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan) Robert G. Smith, Ph.D. (USA), Associate Editor Helen Saul Case, M.S. (USA), Assistant Editor Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor Jason M. Saul, JD (USA), Legal Consultant
作者简介安德鲁·索尔(AndrewSaul)担任自然疗法谘询专家已有30多年了。他拥有博士学位。在人类伦理学中。作为三所大学的作家和资深讲师,他对临床营养的掌握是首屈一指的。他举世闻名,经过同行评审的非商业性自然疗愈网站www.DoctorYourself.com 每天获得超过40,000次点击。《今日心理学》将将AndrewSaul命名为七位自然保健先驱之一。他曾在纪录片《要知道的死亡:自然疗法背后的证据》和非常受欢迎的《食物问题》电影中担任主角。他已撰写或合著了十四本书,其中包括与艾布拉姆·霍弗(AbramHoffer)合作的四本书。索尔(Saul)目前是《基本健康出版社》(BasicHealthPublications)受欢迎的《维生素治疗》(VitaminCure)系列丛书的编辑,有十多种印刷品或正在出版的书名。我们开设了名为MegaVitaminFormulaCourse的常⻅课程。

Leave a Reply

Your email address will not be published. Required fields are marked *